Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-05

Clinical Trial Update: Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

A Phase 4 trial compared etanercept plus methotrexate versus methotrexate alone in rheumatoid arthritis, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etanercept (etanercept)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2012-09-05